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Can we prevent splenic rupture for
patients with infectious mononucleosis?
■ Evidence summary
The annual incidence of infectious
mononucleosis is somewhere between 345
and 671 cases per 100,000 in the US; it is
highest in the adolescent age group.1
Splenic rupture is the leading cause of
death in infectious mononucleosis, occur-
ring in 0.1% to 0.2% of all cases.1–4 Based
on this figure, approximately 100 cases of
rupture may occur yearly in the US, only a
few of which are reported. 
A retrospective analysis of 8116
patients with infectious mononucleosis at
the Mayo Clinic estimated the risk of spon-
taneous splenic rupture to be 0.1% of cases,
correlating with rates found in other studies.
The study’s criteria for definite spontaneous
rupture are: no recent trauma; recent symp-
toms; hematologic, serologic, and histologic
(splenic) evidence of infectious mononucle-
osis. Five patients with rupture (average age,
22) were identified; 3 were male. Splen-
ectomy was performed for all patients.
Follow-up over 33-years found all patients
healthy with minimal subsequent illness.3
A review of 55 cases found almost all
splenic ruptures occurred between the
fourth and twenty-first days of illness, and
that all affected spleens were enlarged,
although only half were palpable on 
exam. Ninety percent of the ruptures
occurred in males, and more than half
were nontraumatic. There was no correla-
tion between severity of illness and suscep-
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All patients with infectious mononucleosis should
be considered at risk for splenic rupture since 
clinical severity, laboratory results, and physical
exam are not reliable predictors of rupture
(strength of recommendation [SOR]: B, case-control
study). Clinical evidence indicates that most splenic
ruptures occur within 4 weeks of symptom onset,
which correlates with ultrasound data showing res-
olution of splenomegaly by 30 days from symptom
onset (SOR: B, case-control study). Given the mor-
bidity and mortality associated with splenic rupture,
instruct patients to refrain from vigorous physical
activity for 1 month after symptom onset (SOR: C,
expert opinion).
E V I D E N C E - B A S E D A N S W E R
Mononucleosis patients should restrict
strenuous activity for 4 weeks from onset 
At the University of Arizona student health cen-
ter, we see over 120 new cases of mononucleosis
each year. No clinicians in our group can recall a
single splenic rupture in 18 years. The quoted
rupture rate of 0.1% based on a study of 8116
patients may be a high estimate and it is likely
that most physicians go through their entire
career without seeing a single case.
For our group, the value of this review was
to point out the lack of correlation with illness
severity, lab abnormalities, or a palpable spleen
in predicting this rare event. Based on this
review, we amended our patient handout to
make more specific our advice about restricting
strenuous physical activity for 4 weeks from the
onset of symptoms. 
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There was no 
correlation
between severity
of illness 
and susceptibility
to splenic rupture
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tibility to splenic rupture. No specifics
were given on duration of illness or how
splenomegaly was diagnosed.4
The best technique for identifying
splenic enlargement and determining risk
of rupture is unclear. In a case-control
study, 29 patients were admitted to an ear,
nose, and throat department with infec-
tious mononucleosis and were evaluated
serially for splenic and hepatic enlarge-
ment by ultrasound. Diagnosis was based
on clinical picture, a positive heterophile
test, and other blood tests. Four patients
were included despite negative serology
due to compelling clinical presentations
and symptoms. Serial ultrasound imaging
showed that all had enlarged spleens
(mean enlargement 50%–60%); 50% had
hepatic enlargement (5%–20% enlarge-
ment). The patients were compared with a
control group of 8 patients admitted with
peritonsillar abscess, as verified by tonsil-
lectomy. No controls had hepatic or
splenic enlargement. Physical examina-
tions detected splenomegaly in only 17%
of the study patients. The exams were con-
ducted by house staff without blinding,
randomization, or tests of reproducibility.
Ultrasound scanning was completed on
days 1, 3, 5, 10, 20, 90, and 120. The
spleen was significantly larger in the infec-
tious mononucleosis group than in the
control group for the first 30 days, and no
difference in size was found over the sub-
sequent 3 months. No correlation existed
between laboratory values and enlarge-
ment of the spleen or liver.5
No quality studies evaluate the risks
of physical activity in infectious mononu-
cleosis. Case reports of rupture have
found comparable rates between traumat-
ic and nontraumatic causes. In addition,
no clinical trials evaluate imaging in deci-
sions regarding return to activity and its
effect on splenic rupture. Ultrasound is
often used in the athletic setting for these
decisions but no evidence supports its use
as routine practice. The routine use of
ultrasound for this purpose would cost
more than $1 million to prevent 1 trau-
matic rupture.6
Recommendations from others
Clinical Sports Medicine recommends ath-
letes refrain from sporting activities until
all acute symptoms resolve and contact
sports avoided while the spleen is enlarged.
No recommendation is given on determin-
ing spleen size.7
Team Physician Handbook recom-
mends athletes do no cardiovascular work,
lifting, strength training, or contact sports
for 2 weeks because of the risk of splenic
rupture. Activity is then gradually
increased as the athlete improves. Athletes
are to avoid contact or weight-lifting for 4
weeks unless they feel well and ultrasound
reveals a normal-sized spleen.8
Sports Medicine Secrets advises ultra-
sound or CT of the spleen to be obtained
if there is any suspicion of splenomegaly
or if return to play before 4 weeks is con-
templated. Light athletic activity may be
resumed approximately 3 weeks after
symptom onset if the spleen is not tender
or enlarged on examination, the patient
is afebrile, liver enzymes are normal, and
all other complications are resolved.
Contact sports may be resumed 4 weeks
after symptom onset if there is no docu-
mentation of splenomegaly, the athlete
feels ready, and all other complications
have resolved.9
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